MYC and lung carcinoma: We identified and confirmed PRKDC (Protein Kinase, DNA-activated, Catalytic polypeptide), a protein kinase with a major role in non-homologous end joining (NHEJ) DNA repair [24, 25]), as a novel synthetic lethal target in MYC-overexpressing lung cancer cells.